INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 37 filers reported holding INMUNE BIO INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,320 | -26.4% | 11,510 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $106,345 | +43.1% | 11,510 | +0.1% | 0.01% | +60.0% |
| Q1 2023 | $74,290 | -14.2% | 11,500 | -15.8% | 0.01% | -16.7% |
| Q4 2022 | $86,547 | -35.4% | 13,651 | -10.0% | 0.01% | -45.5% |
| Q2 2022 | $134,000 | +4.7% | 15,167 | 0.0% | 0.01% | +37.5% |
| Q1 2022 | $128,000 | -17.4% | 15,167 | 0.0% | 0.01% | -20.0% |
| Q4 2021 | $155,000 | -52.2% | 15,167 | -9.0% | 0.01% | -54.5% |
| Q3 2021 | $324,000 | -6.1% | 16,667 | -15.3% | 0.02% | -4.3% |
| Q2 2021 | $345,000 | +47.4% | 19,667 | 0.0% | 0.02% | +35.3% |
| Q1 2021 | $234,000 | -25.2% | 19,667 | +8.3% | 0.02% | -19.0% |
| Q4 2020 | $313,000 | +67.4% | 18,167 | 0.0% | 0.02% | +31.2% |
| Q3 2020 | $187,000 | -84.9% | 18,167 | -92.3% | 0.02% | -86.3% |
| Q2 2020 | $1,239,000 | +46.8% | 235,961 | -6.9% | 0.12% | -2.5% |
| Q1 2020 | $844,000 | -35.2% | 253,461 | +12.8% | 0.12% | -13.7% |
| Q4 2019 | $1,303,000 | -1.7% | 224,667 | 0.0% | 0.14% | -7.9% |
| Q3 2019 | $1,326,000 | – | 224,667 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 230,500 | $2,351,000 | 1.70% |
| Fermata Advisors, LLC | 17,955 | $183,000 | 0.07% |
| Virtu Financial LLC | 24,364 | $249,000 | 0.02% |
| YorkBridge Wealth Partners, LLC | 10,369 | $106,000 | 0.02% |
| Jump Financial, LLC | 21,100 | $215,000 | 0.01% |
| Financial Advocates Investment Management | 15,167 | $155,000 | 0.01% |
| FNY Investment Advisers, LLC | 1,100 | $11,000 | 0.01% |
| Janney Montgomery Scott LLC | 113,914 | $1,162,000 | 0.01% |
| Walleye Capital LLC | 17,127 | $175,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 12,473 | $127,000 | 0.00% |